NASDAQ:ADGI
Delisted

Adagio Therapeutics Stock News

etoro logo Buy ADGI
*Your capital is at risk
$2.47
+0.0900 (+3.78%)
At Close: Jan 27, 2023
WALTHAM, Mass., Jan. 06, 2022 (GLOBE NEWSWIRE) -- Adagio Therapeutics, Inc., (Nasdaq: ADGI) a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of an
Related Stocks: BIIB , IKNA , ABBV , GLPG , SIBN , LUNG , ADGI , ZBH , HCA , ERAS , SGEN , CTKB , PRLD , NTRA , ANTM , AFIB , ABCL , DCPH , AUPH , ASND , TRIL , ARCT , ALXN , ALEC ,

Why Adagio Therapeutics Stock Dived by 13% Today

12:17am, Thursday, 23'rd Dec 2021 The Motley Fool
Another analyst gets notably less bullish on the company''s prospects.

Why Adagio Therapeutics Stock Dived by 13% Today

07:17pm, Wednesday, 22'nd Dec 2021
Another analyst gets notably less bullish on the company's prospects.
Michael Yee, Managing Director at Jefferies, discusses Adagio and its treatment for COVID-19 as well as the outlook for Moderna in 2022 on Yahoo Finance Live.

Adagio Therapeutics (NASDAQ:ADGI) Downgraded by Morgan Stanley to Equal Weight

08:34am, Saturday, 18'th Dec 2021 Dakota Financial News
Morgan Stanley lowered shares of Adagio Therapeutics (NASDAQ:ADGI) from an overweight rating to an equal weight rating in a report released on Tuesday, Analyst Price Targets reports. The firm currently has $11.00 price target on the stock, down from their previous price target of $49.00. Several other equities research analysts also recently weighed in on []
Adagio Therapeutics, Inc. (NASDAQ:ADGI) with the stream of 123.31% also noticed, India Freeport-McMoRan Inc. (NYSE:FCX) encountered a rapid change of 2.77% in the last hour of Thursdays trading session. Adagio The post Eye-catching Hot Stock: Adagio Therapeutics, Inc. (NASDAQ:ADGI), Freeport-McMoRan Inc. (NYSE:FCX) appeared first on Stocks Equity .
Shares of ADGI stock have more than doubled today. With no direct news, investors are curious to know what is driving the price momentum.

Adagio Therapeutics Continues Its Wild Ride How Two Tests Led To A Triple-Digit Gain

06:31pm, Thursday, 16'th Dec 2021 Investor''s Business Daily
New analyses suggest Adagio Therapeutics'' Covid antibody could still tackle the omicron variant and ADGI stock soared on Thursday.
The stock price of Adagio Therapeutics Inc (NASDAQ: ADGI) increased by over 120% today. This is why it happened.
Shares of ADGI stock have more than doubled today. With no direct news, investors are curious to know what is driving the price momentum.
Adagio Therapeutics Inc (NASDAQ: ADGI) is soaring on abnormally-high volume Thursday as traders discuss the stock on various social media platforms. Adagio Therapeutics' average session volume is abou

Why Adagio Therapeutics Stock Is Falling Again Today

06:50pm, Wednesday, 15'th Dec 2021 The Motley Fool
You can always count on investment bank analysts to yell fire after a biotech''s lead program goes up in flames.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE